Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment
- 31 December 2010
- journal article
- Published by Elsevier BV in European Urology
- Vol. 58 (6), 831-835
- https://doi.org/10.1016/j.eururo.2010.08.027
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Risk Stratification of Men Choosing Surveillance for Low Risk Prostate CancerJournal of Urology, 2010
- Empirical Estimates of the Lead Time Distribution for Prostate Cancer Based on Two Independent Representative Cohorts of Men Not Subject to Prostate-Specific Antigen ScreeningCancer Epidemiology, Biomarkers & Prevention, 2010
- Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical ProstatectomyJournal of Clinical Oncology, 2009
- Active surveillance for early‐stage prostate cancerCancer, 2008
- Nomogram use for the prediction of indolent prostate cancerCancer, 2007
- Continuing Controversy Over Monitoring Men With Localized Prostate Cancer: A Systematic Review of Programs in the Prostate Specific Antigen EraJournal of Urology, 2006
- Does PSA Velocity Predict Prostate Cancer in Pre-Screened Populations?European Urology, 2006
- Why do men choose one treatment over another?Cancer, 2006
- The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experienceInternational Journal Of Impotence Research, 2005
- ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinenceNeurourology and Urodynamics, 2004